Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi that infects a
broad range of triatomines and mammalian species, including man. It afflicts 8 million …

Neglected tropical disease (NTD) is a set of 20 deadliest endemic diseases which shows its
presence in most of the developing countries worldwide. Nearly 1 billion of the population …

The objective of the present study was to investigate the influence of the encapsulation
efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes …

Niosomes have been reported as a possible approach to improve the low corneal
penetration and bioavailability characteristics shown by conventional ophthalmic vehicles …

The purpose of this study was to formulate topically effective controlled release ophthalmic
acetazolamide liposomal formulations. Reverse-phase evaporation and lipid film hydration …

Vesicular delivery systems have been reported to serve as local depot for sustained drug
release. Aceclofenac multilamellar liposomes and niosomes were prepared and a …

The full exploration of the 'nutraceuticals' therapeutic potential in cosmetics has been
hindered by their poor stratum corneum permeation. Therefore, the aim of the present study …

Benznidazole, a poorly soluble in water drug, is the first-line medication for the treatment of
Chagas disease, but long treatment periods at high dosages cause several adverse effects …

Chagas disease (CD) is a parasitic zoonosis endemic in Central and South America
affecting nearly 10 million people, with 100 million people at high risk of contracting the …

Hundred years after the discovery of Chagas' disease, there is a lack of effective treatment to
control this neglected disease caused by the parasite Trypanosoma cruzi. The transmission …